Literature DB >> 21046209

Feedback modeling of non-esterified fatty acids in rats after nicotinic acid infusions.

Christine Ahlström1, Lambertus A Peletier, Rasmus Jansson-Löfmark, Johan Gabrielsson.   

Abstract

A feedback model was developed to describe the tolerance and oscillatory rebound seen in non-esterified fatty acid (NEFA) plasma concentrations following intravenous infusions of nicotinic acid (NiAc) to male Sprague-Dawley rats. NiAc was administered as an intravenous infusion over 30 min (0, 1, 5 or 20 μmol kg(-1) of body weight) or over 300 min (0, 5, 10 or 51 μmol kg(-1) of body weight), to healthy rats (n = 63), and serial arterial blood samples were taken for measurement of NiAc and NEFA plasma concentrations. Data were analyzed using nonlinear mixed effects modeling (NONMEM). The disposition of NiAc was described by a two-compartment model with endogenous turnover rate and two parallel capacity-limited elimination processes. The plasma concentration of NiAc was driving NEFA (R) turnover via an inhibitory drug-mechanism function acting on the formation of NEFA. The NEFA turnover was described by a feedback model with a moderator distributed over a series of transit compartments, where the first compartment (M (1)) inhibited the formation of R and the last compartment (M ( N )) stimulated the loss of R. All processes regulating plasma NEFA concentrations were assumed to be captured by the moderator function. The potency, IC (50), of NiAc was 45 nmol L(-1), the fractional turnover rate k ( out ) was 0.41 L mmol(-1) min(-1) and the turnover rate of moderator k ( tol ) was 0.027 min(-1). A lower physiological limit of NEFA was modeled as a NiAc-independent release (k ( cap )) of NEFA into plasma and was estimated to 0.032 mmol L(-1) min(-1). This model can be used to provide information about factors that determine the time-course of NEFA response following different modes, rates and routes of administration of NiAc. The proposed model may also serve as a preclinical tool for analyzing and simulating drug-induced changes in plasma NEFA concentrations after treatment with NiAc or NiAc analogues.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21046209      PMCID: PMC3020290          DOI: 10.1007/s10928-010-9172-2

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  26 in total

1.  Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena.

Authors:  A Sharma; W F Ebling; W J Jusko
Journal:  J Pharm Sci       Date:  1998-12       Impact factor: 3.534

2.  The effect of nicotinic acid on the plasma free fatty acid; demonstration of a metabolic type of sympathicolysis.

Authors:  L A CARLSON; L ORO
Journal:  Acta Med Scand       Date:  1962-12

3.  A nonlinear feedback model capturing different patterns of tolerance and rebound.

Authors:  Johan Gabrielsson; Lambertus A Peletier
Journal:  Eur J Pharm Sci       Date:  2007-06-13       Impact factor: 4.384

Review 4.  Free fatty acid metabolism during myocardial ischemia and reperfusion.

Authors:  S C Hendrickson; J D St Louis; J E Lowe; S Abdel-aleem
Journal:  Mol Cell Biochem       Date:  1997-01       Impact factor: 3.396

5.  Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration.

Authors:  M Wakelkamp; G Alván; J Gabrielsson; G Paintaud
Journal:  Clin Pharmacol Ther       Date:  1996-07       Impact factor: 6.875

6.  Transit compartments versus gamma distribution function to model signal transduction processes in pharmacodynamics.

Authors:  Y N Sun; W J Jusko
Journal:  J Pharm Sci       Date:  1998-06       Impact factor: 3.534

7.  Hormonal regulation of hormone-sensitive lipase in intact adipocytes: identification of phosphorylated sites and effects on the phosphorylation by lipolytic hormones and insulin.

Authors:  P Strålfors; P Björgell; P Belfrage
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

8.  Acute dose-dependent disposition studies of nicotinic acid in rats.

Authors:  M Iwaki; T Ogiso; H Hayashi; T Tanino; L Z Benet
Journal:  Drug Metab Dispos       Date:  1996-07       Impact factor: 3.922

9.  Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin.

Authors:  P L Canner; K G Berge; N K Wenger; J Stamler; L Friedman; R J Prineas; W Friedewald
Journal:  J Am Coll Cardiol       Date:  1986-12       Impact factor: 24.094

10.  Pharmacodynamic models of nitroglycerin-induced hemodynamic tolerance in experimental heart failure.

Authors:  J A Bauer; H L Fung
Journal:  Pharm Res       Date:  1994-06       Impact factor: 4.200

View more
  6 in total

1.  Modeling energy intake by adding homeostatic feedback and drug intervention.

Authors:  Peter Gennemark; Stephan Hjorth; Johan Gabrielsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-11-12       Impact factor: 2.745

2.  Feedback modeling of non-esterified fatty acids in obese Zucker rats after nicotinic acid infusions.

Authors:  Christine Ahlström; Tobias Kroon; Lambertus A Peletier; Johan Gabrielsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-10-10       Impact factor: 2.745

3.  Challenges of a mechanistic feedback model describing nicotinic acid-induced changes in non-esterified fatty acids in rats.

Authors:  Christine Ahlström; Lambertus A Peletier; Johan Gabrielsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-07-04       Impact factor: 2.745

4.  Mixed Effects Modeling Using Stochastic Differential Equations: Illustrated by Pharmacokinetic Data of Nicotinic Acid in Obese Zucker Rats.

Authors:  Jacob Leander; Joachim Almquist; Christine Ahlström; Johan Gabrielsson; Mats Jirstrand
Journal:  AAPS J       Date:  2015-02-19       Impact factor: 4.009

5.  Joint feedback analysis modeling of nonesterified fatty acids in obese Zucker rats and normal Sprague-Dawley rats after different routes of administration of nicotinic acid.

Authors:  Sofia Tapani; Joachim Almquist; Jacob Leander; Christine Ahlström; Lambertus A Peletier; Mats Jirstrand; Johan Gabrielsson
Journal:  J Pharm Sci       Date:  2014-07-01       Impact factor: 3.534

6.  Modeling of free fatty acid dynamics: insulin and nicotinic acid resistance under acute and chronic treatments.

Authors:  Robert Andersson; Tobias Kroon; Joachim Almquist; Mats Jirstrand; Nicholas D Oakes; Neil D Evans; Michael J Chappel; Johan Gabrielsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-02-21       Impact factor: 2.745

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.